Balancing Efficacy, Tolerability and Adherence in Oral Iron Therapy for Non-Dialysis CKD: Expert Insights from Professor Dr Lim Soo Kun

18 hours ago
Balancing Efficacy, Tolerability and Adherence
in Oral Iron Therapy for Non-Dialysis CKD:
Expert Insights from Professor Dr
Anaemia is a highly prevalent complication across the chronic kidney disease (CKD) continuum, increasing in frequency and severity as renal function declines. Professor Dr Lim Soo Kun discusses how managing iron deficiency anaemia (IDA) effectively in non-dialysis CKD patients requires a personalised approach that balances diagnostic precision, formulation selection, patient adherence, and long-term clinical outcomes.
Sponsored as an educational program by ABBOTT LABORATORIES (M) SDN. BHD

Related MIMS Drugs

Resources

MY-ABB-277: Balancing Efficacy, Tolerability and Adherence in Oral Iron Therapy for Non-Dialysis CKD: Expert Insights from Pr MY-ABB-277: Balancing Efficacy, Tolerability and Adherence in Oral Iron Therapy for Non-Dialysis CKD: Expert Insights from Pr

MY-ABB-277: Balancing Efficacy, Tolerability and Adherence in Oral Iron Therapy for Non-Dialysis CKD: Expert Insights from Professor Dr Lim Soo Kun